170 related articles for article (PubMed ID: 15549159)
1. Dynamic evaluation of 18F-FDG uptake by microPET and whole-body autoradiography in a fibrosarcoma-bearing mouse model.
Chang CH; Fan KH; Chen TJ; Hsu WC; Jan ML; Tsai TH; Kao PF; Chen CF; Fu YK; Lee TW
J Formos Med Assoc; 2004 Nov; 103(11):876-81. PubMed ID: 15549159
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal evaluation of tumor metastasis by an FDG-microPet/microCT dual-imaging modality in a lung carcinoma-bearing mouse model.
Chang CH; Jan ML; Fan KH; Wang HE; Tsai TH; Chen CF; Fu YK; Lee TW
Anticancer Res; 2006; 26(1A):159-66. PubMed ID: 16475693
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an intraperitoneal ovarian cancer syngeneic mouse model using 18F-FDG MicroPET imaging.
Lee HJ; Tantawy MN; Nam KT; Choi I; Peterson TE; Price RR
Int J Gynecol Cancer; 2011 Jan; 21(1):22-7. PubMed ID: 21321526
[TBL] [Abstract][Full Text] [Related]
4. Coincidence planar imaging for dynamic [18F]FDG uptake in nude mice with tumors and inflammation: correlated with histopathology and micro-autoradiography.
Sun YL; Jan ML; Kao PF; Fan KH; Hsu HT; Chang WC; Shen YC; Lee TW
Kaohsiung J Med Sci; 2005 Jun; 21(6):258-66. PubMed ID: 16035568
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
6. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
7. Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.
Zhou LN; Wu N; Liang Y; Gao K; Li XY; Zhang LF
World J Surg Oncol; 2015 Mar; 13():111. PubMed ID: 25888731
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
Liu RS; Chou TK; Chang CH; Wu CY; Chang CW; Chang TJ; Wang SJ; Lin WJ; Wang HE
Nucl Med Biol; 2009 Apr; 36(3):305-12. PubMed ID: 19324276
[TBL] [Abstract][Full Text] [Related]
9. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an intraperitoneal ovarian cancer xenograft model in nude rats using noninvasive microPET imaging.
Zavaleta CL; Phillips WT; Bradley YC; McManus LM; Jerabek PA; Goins BA
Int J Gynecol Cancer; 2007; 17(2):407-17. PubMed ID: 17362319
[TBL] [Abstract][Full Text] [Related]
11. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice.
Chang CH; Wang HE; Wu SY; Fan KH; Tsai TH; Lee TW; Chang SR; Liu RS; Chen CF; Chen CH; Fu YK
Anticancer Res; 2006; 26(2A):917-25. PubMed ID: 16619487
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
14. The limitation of PET imaging for biological adaptive-IMRT assessed in animal models.
Christian N; Lee JA; Bol A; De Bast M; Jordan B; Grégoire V
Radiother Oncol; 2009 Apr; 91(1):101-6. PubMed ID: 19097661
[TBL] [Abstract][Full Text] [Related]
15. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts.
Dandekar M; Tseng JR; Gambhir SS
J Nucl Med; 2007 Apr; 48(4):602-7. PubMed ID: 17401098
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the relative uptake of 18F-FDG in mouse fibrosarcoma by rolipram.
Kobayashi K; Hosoi R; Momosaki S; Koike S; Ando K; Nishimura T; Inoue O
Ann Nucl Med; 2002 Nov; 16(7):507-10. PubMed ID: 12508846
[TBL] [Abstract][Full Text] [Related]
18. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
[TBL] [Abstract][Full Text] [Related]
19. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
Oyama N; Kim J; Jones LA; Mercer NM; Engelbach JA; Sharp TL; Welch MJ
Nucl Med Biol; 2002 Nov; 29(8):783-90. PubMed ID: 12453586
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
